Digital x-ray and mammography vendor Fischer Imaging has postponed the release of its second-quarter 2002 earnings report. The Denver firm cited several reasons for the delay.
The firm has created a new division for its noncore digital radiography, electrophysiology, and x-ray product lines, and a complete restructuring, evaluation, and inventory review of these businesses is currently in progress. The company expects restructuring charges and a significant write-down in inventory following completion of this work, Fischer said.
The firm's accountant, Ernst & Young, was just hired in July after former accountant Arthur Andersen was unable to complete accounting work due to the closing of its Denver office. Ernst & Young has not yet had time to complete the accounting or review its predecessor's auditor work papers, and as a result has not completed its SAS-71 review procedures, Fischer said.
Fischer is still evaluating the appropriate accounting treatment of a favorable patent infringement settlement of $25 million awarded during the second quarter from Thermo Electron, the former parent of Trex Medical. Fischer and Thermo Electron earlier this year settled a suit in which Fischer claimed that a Trex biopsy device infringed on its patents. Fischer will also receive $7.2 million in installments from Thermo Electron over the next eight years.
The company said it will announce a new reporting date as soon as possible.
By AuntMinnie.com staff writersAugust 15, 2002
Copyright © 2002 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
